Life sciences funding
Our Early Stage team are helping to turn world-class research and scientific discovery into meaningful patient outcomes. Alongside funding, we bring deep domain expertise and scaling support, with a platform that few early-stage investors can match.
How we're different
We’re uniquely equipped to provide early-stage venture capital, but backed by the platform and resources of a later-stage growth investor:
- Deep technical and commercial expertise
- Evergreen fund structure, purpose-built to drive long-term growth
- Specialist team of investors to support you as you scale, with both life sciences consulting and operating experience
- Built on a foundation of 600+ investments and 200+ exits, across the full BGF portfolio
We’ve invested more than £180m into life sciences startups so far, across our four focus areas:
-
Advanced Tools & Materials
-
Diagnostics
-
MedTech
-
Drug Discovery & Development
Latest news
Investment criteria
To be eligible for funding and support from our Early Stage team, life sciences businesses must be:
- Headquartered in the UK or Ireland
- Privately-owned
- IP-protected
- Late seed to series B
- Seeking £3m-£10m investment from BGF
Meet the team
-
• Leadership
Tim Rea
Co-Head of Early Stage
-
• Early Stage
Luke Rajah
Portfolio Partner
-
• Early Stage
Lucy Edwardes Jones
Investor
-
• Early Stage
Math Williams
Investor
-
• Early Stage
Maggy Lau
Investor
-
• Early Stage
Talia Hoffman
Portfolio
Join our portfolio
Across BGF, we’ve already helped hundreds of ambitious businesses to accelerate their growth. Yours could be next. Introduce yourself to our Early Stage team today to get started.